Work

Selection of Rilpivirine Resistant HIV-1 in a Seroconverter on Long-acting Rilpivirine (TMC278LA) from the Lowest Dose Arm of the SSAT 040 Trial

Year: 2014

Type: conference-abstract

Source: AIDS Research and Human Retroviruses

DOI: 10.1089/aid.2014.5127.abstract

Authors: Kerri J. Penrose, Urvi M. Parikh, Kristen A. Hamanishi, Constantinos Panousis, Laura Else, David Back, Marta Boffito, Akil Jackson, John W. Mellors

Institutions: University of Pittsburgh, University of Liverpool, Chelsea and Westminster Hospital

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2341474797

Cites:

Cited by: 6

Related to: 10